The technology uses DNA nanostructures paired with nanopore sensing to potentially detect hundreds of targets per sample.
The Chengdu-based company, cofounded by a former Illumina employee, said it will use the money to expand its product portfolio and accelerate commercialization.
Late-Onset Ataxia Linked to New Repeat Expansion in FGF14 Gene
The repeat expansion appears to coincide with late-onset cerebellar ataxia risk, particularly in patients from a French-Canadian population.
With rapid nanopore whole-genome sequencing and targeted analysis, researchers can determine a newborn's genetic risk for a disorder in three hours.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.